Compare e l f Beauty Inc (ELF) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
e l f Beauty Inc vs 22nd Century Group Inc — how do they compare? e l f Beauty Inc trades at $109.23 (market cap $6.25B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: e l f Beauty Inc is far larger — about 10053.6× 22nd Century Group Inc's market cap, and e l f Beauty Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold e l f Beauty Inc for 25 Days and 22nd Century Group Inc for 32 Days on average.
| ELF | XXII | |
|---|---|---|
Market Cap | $6.25B | $621.67K |
Volume | 1,099,552 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $144.97 | $483.00 |
52-Week Low | $49.57 | $0.80 |
Typical Hold Time | 25 Days | 32 Days |
Enterprise Value | $6.84B | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ELF Beauty trades at $109.23, up 4.0% today, showing strong momentum with three consecutive earnings beats and bullish technical signals. The stock's premium valuation (P/E 108.12) reflects high growth expectations as revenue surged to $1.31B in 2025 with 74.44% gross margins. Recent expansion into European markets via Sephora and innovative marketing campaigns like the 'Mirror Mix' album highlight aggressive growth strategies. Analyst sentiment is mixed with 48% buy ratings but a consensus price target of $95.91 suggests caution near current levels.
ELF's growth trajectory remains compelling with international expansion and product innovation driving revenue, though elevated valuation and declining net margins (3.38% in 2026) pose risks. Institutional buying supports bullish sentiment, but investors should monitor execution of expansion plans and competitive pressures in the beauty sector. The stock trades above analyst targets, indicating limited near-term upside without further earnings surprises.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About e l f Beauty Inc
e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
